Lili Huang

机构：Guangdong Pharmaceutical University, Guangzhou Center for Disease Control and Prevention, Henan Provincial Center for Disease Control and Prevention · ORCID：0000-0003-3084-4936

发表论文 34 篇 · 总被引 1308 次 · h-index 8

代表论文

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes (2020 · JAMA · 被引 807)
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial (2021 · The Lancet Infectious Diseases · 被引 202)
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial (2021 · EClinicalMedicine · 被引 40)
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial (2022 · Frontiers in Immunology · 被引 21)
Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older: A randomized, double-blind, controlled study (2023 · Vaccine · 被引 7)
Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months (2023 · International Journal of Infectious Diseases · 被引 7)